Compounds > 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone
Page last updated: 2024-09-03

4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone and Kidney Neoplasms

4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone has been researched along with Kidney Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, S; Clague, J; Lin, J; Shao, L; Wang, W; Wood, CG; Wu, X; Zhu, Y1

Other Studies

1 other study(ies) available for 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone and Kidney Neoplasms

ArticleYear
Sensitivity to NNKOAc is associated with renal cancer risk.
    Carcinogenesis, 2009, Volume: 30, Issue:4

    Topics: Case-Control Studies; Comet Assay; DNA Damage; DNA Repair; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Lymphocytes; Male; Middle Aged; Nitrosamines; Pyridines; Risk Factors; Smoking

2009